Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

23.49 +0.04 (+0.17%)
Official Closing Price Updated: 7:00 PM EDT, May 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Beat the S&P 500 With This Cash-Gushing Dividend Stock
The business may be somewhat boring, but it consistently delivers year after year, resulting in tremendous long-term returns. 
Via The Motley Fool
Topics Artificial Intelligence Bonds Intellectual Property
Exposures Artificial Intelligence Debt Markets Intellectual Property
Pfizer Reports Survival Gains In Colorectal Cancer Study, Combo Therapy Cuts Death Risk By Over 50%
Pfizer's BRAFTOVI combo cut death risk by 51% and more than doubled survival in BRAF-mutant colorectal cancer in a Phase 3 trial. 
Via Benzinga
2 Large-Cap Stocks to Target This Week and 1 to Keep Off Your Radar
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an... 
Via StockStory
Pfizer's Mega Deal Highlights China's Rising Role In Global Pharma
Via Benzinga
Robert F. Kennedy Jr. Says CDC Drops COVID Vaccine For 'Healthy' Pregnant Women, Children
RFK Jr. says the COVID-19 vaccine is no longer on the CDC's recommended schedule for healthy kids and pregnant women, though the official site still shows it listed. 
Via Benzinga
Exposures COVID-19
P/E Ratio Insights for Pfizer
Via Benzinga
How Do Investors Really Feel About Pfizer?
Via Benzinga
Is Pfizer Stock a Buy After This $1.25 Billion Investment?
Via The Motley Fool
Exposures COVID-19
Down 63%, Should You Buy the Dip on Pfizer?
Pfizer has taken its lumps lately. It's time to wonder whether the stock can make a comeback. 
Via The Motley Fool
Topics Economy Government World Trade
Exposures COVID-19 Interest Rates Political
1 Ultra-High-Yield Dividend Stock Down 57% to Buy Hand Over Fist
Via The Motley Fool
Topics Government Intellectual Property World Trade
Exposures COVID-19 Intellectual Property Political
U.S. Pharmaceutical Imports Might Soon Face Tariffs: 3 Stocks That Could Tumble as a Result
There's little doubt these pharmaceutical companies' costs will soon be rising at least a little. 
Via The Motley Fool
Topics Government Supply Chain World Trade
Exposures Political Supply Chain Tariff
Pfizer's 7.5% Dividend: Income Haven or House of Cards?
Pfizer's high dividend yield warrants scrutiny regarding its sustainability, given changing revenues and pipeline investments. 
Via MarketBeat
Exposures COVID-19
Pfizer Stock Analysis: Buy, Sell, or Hold?
Via The Motley Fool
3 Stocks Under $10 Skating on Thin Ice
Stocks under $10 pique our interest because they have room to grow (as well as the most affordable option contract premiums). That doesn’t mean they’re bargains though, and we urge investors to be... 
Via StockStory
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
Via Benzinga
FDA Limits Annual COVID-19 Boosters To High-Risk Americans, Demands New Trials For Healthy Adults In Policy Shift Under RFK Jr.
The U.S. Food and Drug Administration has announced significant changes to COVID-19 vaccine requirements, limiting annual booster approvals to older and high-risk Americans while implementing stricter... 
Via Benzinga
Exposures COVID-19 Product Safety
2 High-Yield Dividend Stocks to Buy Right Now
Via The Motley Fool
Topics Earnings Intellectual Property
Exposures COVID-19 Financial Intellectual Property
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030
Via The Motley Fool
Topics Economy Law Enforcement
Exposures Economy Legal Product Safety
Stay informed about the most active stocks in the S&P500 index on Tuesday's session.
Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention. 
Via Chartmill
Pfizer Stock Is Trading Higher Tuesday: What's Going On?
Pfizer Inc (NYSE:PFE) shares are moving higher Tuesday following multiple developments. Here's a look at what's going on. 
Via Benzinga
FDA Sets New Guidelines For Approving COVID-19 Booster Shots In Healthy Individuals: Moderna, Novavax Stocks Rise
The agency plans to demand stronger evidence of efficacy for the shots before approval is granted for healthy persons, between the ages of six months and 64 years, with no risk factors for severe... 
Via Stocktwits
Exposures COVID-19 Product Safety
The FDA Is Limiting Covid Shots. But Moderna, Vaccine Stocks Jumped.
The new framework limits future Covid shots to people age 65 and older and those six months and older with a risk factor for serious illness. 
Via Investor's Business Daily
Topics Bankruptcy Government
Exposures COVID-19 Financial Legal
WeRide Teams Up With Tencent Cloud To Accelerate Global Robotaxi Ambitions
The company said Tencent Cloud will allow it to offer localized and compliant cloud services in countries outside of China, accelerating the commercial rollout of its robotaxi services overseas. 
Via Stocktwits
Topics Supply Chain
Exposures Supply Chain
Pfizer Strikes Deal With China’s 3SBio For Experimental Cancer Drug License
3SBio’s experimental cancer drug is currently undergoing clinical trials in China for non-small cell lung cancer, metastatic colorectal cancer, and gynecological tumors. 
Via Stocktwits
Topics Government
Exposures Political
Sell-Off Grips Dalal Street: Nifty Ends Below 24,700; Metals Shine On China Rate Cut
Indian markets ended sharply lower, dragged by broad-based profit booking, FPI outflows, and fading optimism over the U.S.-India trade deal. 
Via Stocktwits
Topics Economy
Exposures Coal Economy Interest Rates
These 3 Dividend Stocks Yield More Than 6% and Their Payouts Look Safe
Via The Motley Fool
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Pfizer Secures Global Rights To China's 3SBio's Cancer Drug In $6 Billion Deal
Pfizer Inc. announced Monday it has secured exclusive global rights, excluding China, to 3SBio Inc.'s bispecific antibody SSGJ-707. 
Via Benzinga
Retail Bulls Cheer FDA Clearance For BrainStorm’s ALS Therapy, But Shares Dip After Hours
BrainStorm Cell Therapeutics plans to enroll 200 ALS patients in its FDA-cleared Phase 3b trial of NurOwn, with a 24-week double-blind phase followed by an open-label extension. 
Via Stocktwits
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Novavax Scores Key FDA Win, Shares Jump 19% As Sanofi Unlocks Milestone Payment
Novavax's COVID-19 vaccine, Nuvaxovid™, receives limited FDA approval and triggers $175M milestone payment. Commercial distribution planned for fall. 
Via Benzinga
Exposures COVID-19 Product Safety
Novavax Wins Limited FDA Nod For COVID Shot—Cleared Only For Seniors, High-Risk Groups Amid Safety Scrutiny
The U.S. Food and Drug Administration has granted limited approval to Novavax Inc.'s COVID-19 vaccine, restricting its use to people 65 and older and those 12 and up with underlying health conditions... 
Via Benzinga
Exposures COVID-19 Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.